September 28, 2016
Cells that Normally Protect Motor Neurons Acquire Toxic Effects in ALS, Study Suggests

Several studies have shown that oligodendrocytes, cells that normally protect neurons, can also contribute to neuronal death in amyotrophic lateral sclerosis (ALS). Now, researchers demonstrate this ... Read more
September 27, 2016
Second Phase 2 Trial of NP001 for ALS Therapy is Underway

Neuraltus Pharmaceuticals has initiated the second Phase 2 clinical trial of NP001 for the treatment of amyotrophic lateral sclerosis (ALS), with the goal of ... Read more
September 26, 2016
Engineered Protein Mutation Prevented Clumping in ALS Motor Neurons

By introducing a mutation in SOD1 — the protein believed to be responsible for a large part of amyotrophic lateral sclerosis (ALS) cases — researchers ... Read more
September 23, 2016
Smoking Speeds Progression of ALS and Reduces Survival Longevity

Cigarette smoking may speed progression of amyotrophic lateral sclerosis (ALS) and reduce survival in patients with the disease, according to a new collaborative study from Italian universities ... Read more
September 22, 2016September 22, 2016
Chronic Respiratory Support May Decrease Quality of Life in ALS Patients, Study Suggests

Most patients with amyotrophic lateral sclerosis (ALS) develop respiratory problems in the advanced stage of their disease and are put on chronic ventilator support to improve ... Read more